Related references
Note: Only part of the references are listed.Nano-Polyplexes Mediated Transfection of Runx2-shRNA Mitigates the Osteodifferentiation of Human Valvular Interstitial Cells
Geanina Voicu et al.
PHARMACEUTICS (2020)
99MTC-FUCOIDAN AS DIAGNOSTIC AGENT FOR P-SELECTIN IMAGING: FIRST-IN-HUMAN EVALUATION (PHASE I)
K. H. Zheng et al.
ATHEROSCLEROSIS (2019)
Functional Role of VCAM-1 Targeted Flavonoid-Loaded Lipid Nanoemulsions in Reducing Endothelium Inflammation
Elena Valeria Fuior et al.
PHARMACEUTICS (2019)
Targeting P-Selectin Adhesion Molecule in Molecular Imaging: P-Selectin Expression as a Valuable Imaging Biomarker of Inflammation in Cardiovascular Disease
Lydia A. Perkins et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris
Genny Degani et al.
GLYCOCONJUGATE JOURNAL (2019)
Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells
Cristina Ana Constantinescu et al.
PHARMACEUTICS (2019)
Study of the Efficiency of the Hydroporation for Delivery of Plasmid DNA to the Cells on the Model of Toxic Neuropathy
M. A. Yudin et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells
Victoria L. M. Herrera et al.
NANOMEDICINE (2018)
Imaging breast cancer using a dual-ligand nanochain particle
Gil Covarrubias et al.
PLOS ONE (2018)
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice
Peicheng Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome
Shiran Ferber et al.
ELIFE (2017)
Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling
Hongli Gao et al.
MEDICAL SCIENCE MONITOR (2017)
Exploring the in vivo toxicity of nanoparticles
L. Romero-Castillo et al.
CANADIAN JOURNAL OF CHEMISTRY (2017)
2016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis an Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage
Ann Marie Schmidt
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Emerging Nanocarriers-based Approaches to Diagnose and Reduce Vascular Inflammation in Atherosclerosis
Manuela Calin et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Assessing the welfare of laboratory mice in their home environment using animal-based measures - a benchmarking tool
Elin M. F. Spangenberg et al.
LABORATORY ANIMALS (2016)
P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation
Viorel Simion et al.
MEDIATORS OF INFLAMMATION (2016)
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
Yosi Shamay et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial
Barbara E. Stahli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes
Manuela Calin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells
Piotr S. Kowalski et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
A1-42 oligomer-induced leakage in an invitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins
Wenbin Wan et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Targeting P-Selectin by Gallium-68-Labeled Fucoidan Positron Emission Tomography for Noninvasive Characterization of Vulnerable Plaques Correlation With In Vivo 17.6T MRI
Xiang Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Spatiotemporal complexity of the aortic sinus vortex
Brandon Moore et al.
EXPERIMENTS IN FLUIDS (2014)
Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo
Piotr S. Kowalski et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Biodistribution of P-selectin targeted microbubbles
Jason M. Warram et al.
JOURNAL OF DRUG TARGETING (2014)
Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis
Xiao-Gang Cai et al.
MOLECULAR MEDICINE REPORTS (2014)
Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley rats
Lei Xu et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Complex Tissue-Specific Patterns and Distribution of Multiple RAGE Splice Variants in Different Mammals
Raquel Lopez-Diez et al.
GENOME BIOLOGY AND EVOLUTION (2013)
Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis
Chang Hoon Ha et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Reduced in vitro and in vivo toxicity of siRNA-lipoplexes with addition of polyglutamate
Anne Schlegel et al.
JOURNAL OF CONTROLLED RELEASE (2013)
An update on advanced glycation endproducts and atherosclerosis
Serena Del Turco et al.
BIOFACTORS (2012)
In Vivo Delivery Aspects of miRNA, shRNA and siRNA
N. I. Khatri et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts
Wei Wei et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Liposome-based DNA carriers may induce cellular stress response and change gene expression pattern in transfected cells
Anna Fiszer-Kierzkowska et al.
BMC MOLECULAR BIOLOGY (2011)
Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression
Samuel Morris-Rosenfeld et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis
Marie-Josee Jacobin-Valat et al.
NMR IN BIOMEDICINE (2011)
Curcumin and a Morus alba Extract Reduce Pro-Inflammatory Effects of Resistin in Human Endothelial Cells
Monica Madalina Pirvulescu et al.
PHYTOTHERAPY RESEARCH (2011)
Morus alba EXTRACT AND CURCUMIN REDUCE RESISTIN INDUCED-HUMAN ENDOTHELIAL CELLS ACTIVATION BY A MECHANISM INVOLVING P38 MAPK
M. M. Pirvulescu et al.
ATHEROSCLEROSIS SUPPLEMENTS (2010)
The RAGE Axis A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature
Shi Fang Yan et al.
CIRCULATION RESEARCH (2010)
Efficient and targeted delivery of siRNA in vivo
Min Suk Shim et al.
FEBS JOURNAL (2010)
HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells
Zheng-Gang Luan et al.
IMMUNOBIOLOGY (2010)
Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro - A quantitative study
Sigridur A. Asgeirsdottir et al.
JOURNAL OF CONTROLLED RELEASE (2010)
The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis
Lasse Ramsgaard et al.
PLOS ONE (2010)
Reduced seed region-based off-target activity with lentivirus-mediated RNAi
Richard A. Klinghoffer et al.
RNA (2010)
Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis
Janka Kisucka et al.
BLOOD (2009)
Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development
D. D. Rao et al.
CANCER GENE THERAPY (2009)
Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines
Julia V. Gefter et al.
CELL AND TISSUE RESEARCH (2009)
Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia
Manuela Voinea Calin et al.
CELL AND TISSUE RESEARCH (2009)
Evaluation of proinflammatory cytokine production and liver injury induced by plasmid DNA/cationic liposome complexes with various mixing ratios in mice
Yoshitaka Ito et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene
Anastasia Z. Kalea et al.
FASEB JOURNAL (2009)
TLR9-dependent systemic interferon-β production by intravenous injection of plasmid DNA/cationic liposome complex in mice
Hiroyuki Yoshida et al.
JOURNAL OF GENE MEDICINE (2009)
Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide
Martina A. McAteer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE(-/-) mice
Evis Harja et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
RAGE signaling sustains inflammation and promotes tumor development
Christoffer Gebhardt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Potency of siRNA versus shRNA mediated knockdown in vivo
Marie A. McAnuff et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin
Valeria V. Orlova et al.
EMBO JOURNAL (2007)
Suppression of rage as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes
Chiara Cuccurullo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor α in experimental arthritis
M Khoury et al.
ARTHRITIS AND RHEUMATISM (2006)
Peroxisome proliferator-activated receptor γ down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model
K Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
K Nakamura et al.
MICROVASCULAR RESEARCH (2005)
Neutral postgrafted colloidal particles for gene delivery
B Thompson et al.
BIOCONJUGATE CHEMISTRY (2005)
Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice
QL Fan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Correlation between structure and transfection efficiency: a study of DC-Chol-DOPE/DNA complexes
A Congiu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques - Role of glycemic control
F Cipollone et al.
CIRCULATION (2003)
P-selectin as a candidate target in atherosclerosis
TJM Molenaar et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Mechanism of lipoplex gene delivery in mouse lung:: binding and internalization of fluorescent lipid and DNA components
LS Uyechi et al.
GENE THERAPY (2001)
Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: Plasmid DNA complexes in mice
JD Tousignant et al.
HUMAN GENE THERAPY (2000)
Prominent role of P-selectin in the development of advanced atherosclerosis in apoE-deficient mice
ZM Dong et al.
CIRCULATION (2000)
Share Paper
